ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,462,383 | +6.2% | 967,146 | +9.4% | 0.67% | +10.6% |
| Q2 2023 | $3,261,377 | -4.9% | 883,842 | -14.7% | 0.60% | -10.3% |
| Q1 2023 | $3,428,339 | -49.5% | 1,035,752 | -40.8% | 0.67% | -52.1% |
| Q4 2022 | $6,788,440 | +95.7% | 1,749,598 | +22.6% | 1.40% | +86.3% |
| Q3 2022 | $3,468,000 | +40.3% | 1,427,160 | +14.3% | 0.75% | +25.0% |
| Q2 2022 | $2,471,000 | – | 1,248,136 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
| Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
| Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
| AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
| Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
| Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
| Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
| OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
| EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |